Clinical and Laboratory Predictors of Esophageal Varices in Children with Chronic Liver Disease

M I Hasan1, M Rukunuzzaman, M Nurullah

  • 1Dr Muhammad Ismail Hasan, FCPS Student, On Deputation, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Insights

Splenomegaly, low platelet count, and low serum albumin are key indicators for predicting esophageal varices in children with chronic liver disease. These factors can help identify at-risk patients, potentially reducing the need for invasive endoscopies.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Clinical Diagnostics

Background:

  • Esophageal varices are a severe complication of portal hypertension in pediatric chronic liver disease.
  • Noninvasive markers are sought to minimize unnecessary endoscopies for screening esophageal varices.
  • Identifying predictors is crucial for early detection and management in children.

Purpose of the Study:

  • To identify clinical and laboratory predictors of esophageal varices in children with chronic liver disease.
  • To evaluate the diagnostic utility of splenomegaly, platelet count, and serum albumin levels.

Main Methods:

  • A cross-sectional observational study involving 50 children under 15 with chronic liver disease.
  • Clinical, biochemical, and endoscopic evaluations were performed.
  • Patients were categorized into groups with and without esophageal varices based on endoscopic findings.

Main Results:

  • Splenomegaly was significantly more prevalent in children with esophageal varices (p<0.05).
  • Lower platelet counts (<1,50,000/mm³) and serum albumin (<3.5mg/dl) were significantly higher in the esophageal varices group (p<0.05).
  • Jaundice, spider angioma, hepatomegaly, ascites, serum bilirubin, ALT, and INR showed no significant difference between groups.

Conclusions:

  • Splenomegaly, platelet count <1,50,000/mm³, and serum albumin <3.5mg/dl are significant predictors of esophageal varices in children with chronic liver disease.
  • These parameters can be independently utilized for predicting esophageal varices, aiding in clinical decision-making.
  • Further research can validate these noninvasive markers for routine screening.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
688
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
771
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.3K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
399